Published in EMBO J on August 03, 1998
Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci U S A (2003) 2.28
Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J (2000) 2.24
Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci U S A (2001) 2.19
Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J (2002) 2.13
Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 2.12
The collagen family. Cold Spring Harb Perspect Biol (2011) 2.10
New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci (2002) 1.58
Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice. Mol Cell Biol (2001) 1.51
Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci U S A (2000) 1.42
The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance. J Cell Biol (2001) 1.34
Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J (2003) 1.34
The lens capsule. Exp Eye Res (2008) 1.32
Molecular interplay between endostatin, integrins, and heparan sulfate. J Biol Chem (2009) 1.25
Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain. J Cell Biol (2001) 1.20
Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formation. J Biol Chem (2010) 1.19
Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators. Dev Dyn (2008) 1.10
Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J (2002) 1.07
Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am J Hum Genet (2002) 1.04
In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences. PLoS One (2009) 1.02
Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration. Arch Ophthalmol (2008) 0.99
The corneal epithelial basement membrane: structure, function, and disease. Invest Ophthalmol Vis Sci (2013) 0.98
Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis. FEBS Lett (2008) 0.98
The first draft of the endostatin interaction network. J Biol Chem (2009) 0.98
Endostatin regulates branching morphogenesis of renal epithelial cells and ureteric bud. Proc Natl Acad Sci U S A (2001) 0.98
Esophageal muscle physiology and morphogenesis require assembly of a collagen XIX-rich basement membrane zone. J Cell Biol (2004) 0.97
A cryptic frizzled module in cell surface collagen 18 inhibits Wnt/beta-catenin signaling. PLoS One (2008) 0.96
The molecular structure of human tissue type XV presents a unique conformation among the collagens. Biochem J (2007) 0.95
Hemicentin 2 and Fibulin 1 are required for epidermal-dermal junction formation and fin mesenchymal cell migration during zebrafish development. Dev Biol (2012) 0.95
Antiangiogenic therapy in brain tumors. Expert Rev Neurother (2008) 0.95
Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro. BMC Musculoskelet Disord (2006) 0.94
Crystal structure of human collagen XVIII trimerization domain: A novel collagen trimerization Fold. J Mol Biol (2009) 0.94
Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro. World J Gastroenterol (2002) 0.92
Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding. Am J Pathol (1999) 0.92
Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am J Pathol (2004) 0.92
Improved stability of multivalent antibodies containing the human collagen XV trimerization domain. MAbs (2012) 0.90
Endostatin overexpression specifically in the lens and skin leads to cataract and ultrastructural alterations in basement membranes. Am J Pathol (2005) 0.89
Endostatin expression in pancreatic tissue is modulated by elastase. Br J Cancer (2005) 0.89
Crystal structure of the human collagen XV trimerization domain: a potent trimerizing unit common to multiplexin collagens. Matrix Biol (2010) 0.89
Homozygosity mapping and whole exome sequencing reveal a novel homozygous COL18A1 mutation causing Knobloch syndrome. PLoS One (2014) 0.89
Regulation of thrombospondin1 by extracellular proteases. Curr Drug Targets (2008) 0.89
Hypoxia-induced increase of endostatin in murine aorta and lung. Histochem Cell Biol (2006) 0.86
Novel pathogenic mutations and skin biopsy analysis in Knobloch syndrome. Mol Vis (2009) 0.85
Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients. Mediators Inflamm (2005) 0.85
Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex. World J Gastroenterol (2003) 0.85
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. Biochim Biophys Acta (2015) 0.84
Retrovirus-mediated gene transfer of human endostatin inhibits growth of human liver carcinoma cells SMMC7721 in nude mice. World J Gastroenterol (2002) 0.82
Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers. Adv Drug Deliv Rev (2015) 0.82
Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates. Biochem J (2003) 0.82
Collagen XVIII/endostatin shows a ubiquitous distribution in human ocular tissues and endostatin-containing fragments accumulate in ocular fluid samples. Graefes Arch Clin Exp Ophthalmol (2006) 0.82
Cellular actions and signaling by endostatin. Crit Rev Eukaryot Gene Expr (2002) 0.82
Lack of collagen XVIII long isoforms affects kidney podocytes, whereas the short form is needed in the proximal tubular basement membrane. J Biol Chem (2010) 0.81
Structural and functional characterization of the human and mouse fibulin-1 gene promoters: role of Sp1 and Sp3. Biochem J (2002) 0.81
Laminins and retinal vascular development. Cell Adh Migr (2012) 0.80
Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture. World J Gastroenterol (2007) 0.79
Endostatin expression in a pancreatic cell line is modulated by a TNFalpha-dependent elastase. Br J Cancer (2005) 0.78
Elective orthopedic and cardiopulmonary bypass surgery causes a reduction in serum endostatin levels. Eur J Med Res (2014) 0.77
Dependence of cathepsin L-induced coronary endothelial dysfunction upon activation of NAD(P)H oxidase. Microvasc Res (2009) 0.77
Delivery of endostatin in experimental cancer therapy. Int J Exp Pathol (2002) 0.75
Protein expression pattern of collagen type XV in mouse cornea. Graefes Arch Clin Exp Ophthalmol (2004) 0.75
The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering. Adv Pharm Bull (2017) 0.75
Serum level of the circulating angiogenesis inhibitor endostatin in patients with hyperthyroidism or hypothyroidism. Wien Klin Wochenschr (2003) 0.75
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 13.76
Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med (1995) 9.02
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (1997) 7.66
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A (1990) 5.26
Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med (1996) 3.64
CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol (1997) 3.52
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol (1993) 3.15
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science (1990) 3.02
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol (1990) 2.69
The reaction of phenylglyoxal with arginine residues in proteins. J Biol Chem (1968) 2.67
Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci U S A (1987) 2.50
Properties of the extracellular calcium binding module of the proteoglycan testican. FEBS Lett (1997) 2.08
Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A (1991) 1.94
Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc Natl Acad Sci U S A (1994) 1.68
Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem (1997) 1.68
Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem (1996) 1.63
Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci U S A (1995) 1.63
A single EGF-like motif of laminin is responsible for high affinity nidogen binding. EMBO J (1993) 1.62
Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc Natl Acad Sci U S A (1994) 1.61
Antibodies to collagens and procollagens. Methods Enzymol (1982) 1.60
Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. J Biol Chem (1996) 1.53
The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology (1993) 1.50
Identification of the molecular recognition sequence which determines the type-specific assembly of procollagen. EMBO J (1997) 1.42
Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics (1994) 1.38
Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J Cell Biochem (1993) 1.37
Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding. J Cell Biol (1993) 1.34
Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J (1998) 1.31
Primary structure of the alpha 1 chain of mouse type XVIII collagen, partial structure of the corresponding gene, and comparison of the alpha 1(XVIII) chain with its homologue, the alpha 1(XV) collagen chain. J Biol Chem (1994) 1.30
A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci U S A (1995) 1.21
Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. EMBO J (1998) 1.21
Binding of mouse and human fibulin-2 to extracellular matrix ligands. J Mol Biol (1995) 1.17
Isolation and characterization of the circulating form of human endostatin. FEBS Lett (1997) 1.16
Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J Cell Physiol (1993) 1.16
Expression of fibulin-2 by fibroblasts and deposition with fibronectin into a fibrillar matrix. J Cell Sci (1996) 1.16
Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides. Eur J Biochem (1997) 1.15
Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. Am J Pathol (1985) 1.14
Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif. Eur J Biochem (1995) 1.05
Identification of a novel collagen chain represented by extensive interruptions in the triple-helical region. Biochem Biophys Res Commun (1993) 0.98
Sulfatide-binding domain of the laminin A chain. J Biol Chem (1990) 0.98
Glycosylated threonine but not 4-hydroxyproline dominates the triple helix stabilizing positions in the sequence of a hydrothermal vent worm cuticle collagen. J Mol Biol (1996) 0.98
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell (1997) 13.53
Laminin--a glycoprotein from basement membranes. J Biol Chem (1979) 12.49
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science (1996) 5.13
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell (1996) 5.10
Characterization of collagen peptides by sodium dodecylsulfate-polyacrylamide electrophoresis. Anal Biochem (1971) 4.75
Residential exposure to traffic is associated with coronary atherosclerosis. Circulation (2007) 4.68
A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem (1981) 4.19
Two improved methods for preparing ferritin-protein conjugates for electron microscopy. J Cell Biol (1975) 3.81
Laminin and other basement membrane components. Annu Rev Cell Biol (1987) 3.73
The heparin-binding domain of laminin is responsible for its effects on neurite outgrowth and neuronal survival. EMBO J (1984) 3.39
Skin and hair follicle integrity is crucially dependent on beta 1 integrin expression on keratinocytes. EMBO J (2000) 3.32
Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix. J Mol Biol (1981) 3.15
Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol (1999) 2.94
The J1 glycoprotein--a novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature (1985) 2.92
Role of laminin A chain in the development of epithelial cell polarity. Cell (1988) 2.86
Induction of a basement membrane glycoprotein in embryonic kidney: possible role of laminin in morphogenesis. Proc Natl Acad Sci U S A (1980) 2.74
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J Immunol (1990) 2.55
Integrin recognition of different cell-binding fragments of laminin (P1, E3, E8) and evidence that alpha 6 beta 1 but not alpha 6 beta 4 functions as a major receptor for fragment E8. J Cell Biol (1990) 2.50
Protease resistance and conformation of laminin. Eur J Biochem (1982) 2.47
Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet (2001) 2.43
Lack of beta 1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts. J Cell Biol (1995) 2.39
Nature of the collagenous protein in a tumor basement membrane. Eur J Biochem (1978) 2.35
Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. Am J Hum Genet (1988) 2.34
Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen. Proc Natl Acad Sci U S A (1978) 2.32
Electron-microscopical approach to a structural model of intima collagen. Biochem J (1983) 2.32
Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J (1999) 2.31
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28
Preparation and use in immunohistology of antibodies specific for type I and type III collagen and procollagen. J Immunol Methods (1976) 2.28
Appearance and distribution of collagens and laminin in the early mouse embryo. Dev Biol (1980) 2.27
Substrate adhesion of rat hepatocytes: mechanism of attachment to collagen substrates. Cell (1981) 2.26
Structure, development, and molecular pathology of basement membranes. Int Rev Exp Pathol (1986) 2.25
Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J (2000) 2.24
Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut (1980) 2.24
The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry (2010) 2.23
Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23
Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J Biol Chem (1994) 2.22
Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev (2001) 2.20
Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest (2001) 2.20
7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem (1980) 2.19
Laminin-nidogen complex. Extraction with chelating agents and structural characterization. Eur J Biochem (1987) 2.15
In vivo and in vitro observations on laminin production by Schwann cells. Proc Natl Acad Sci U S A (1983) 2.10
Properties of the extracellular calcium binding module of the proteoglycan testican. FEBS Lett (1997) 2.08
Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res (1987) 2.03
Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell (1984) 2.03
Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin. Proc Natl Acad Sci U S A (1981) 2.03
The production of specific antibodies to native collagens with the chain compositions, (alpha1(I))3, (alpha1(II))3, and (alpha1(I))2alpha 2. J Immunol (1974) 2.02
Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett (1991) 2.02
Repaglinide in the management of new-onset diabetes mellitus after renal transplantation. Am J Transplant (2006) 2.01
Simultaneous synthesis of types I and III collagen by fibroblasts in culture. Proc Natl Acad Sci U S A (1976) 1.97
Macromolecular structure of basement membrane collagens. FEBS Lett (1981) 1.96
Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci U S A (1994) 1.96
Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization. Eur J Biochem (1980) 1.96
Crystal structure and mutational analysis of a perlecan-binding fragment of nidogen-1. Nat Struct Biol (2001) 1.96
Evidence for simian virus 40 (SV40) coding of SV40 T-antigen and the SV40-specific proteins in HeLa cells infected with nondefective adenovirus type 2-SV40 hybrid viruses. J Virol (1977) 1.94
Role of cysteine residues in regulation of p53 function. Mol Cell Biol (1995) 1.91
Immunochemistry, genuine size and tissue localization of collagen VI. Eur J Biochem (1984) 1.91
Adhesion, growth, and matrix production by fibroblasts on laminin substrates. J Cell Biol (1983) 1.91
Biosynthesis of two subunits of type IV procollagen and of other basement membrane proteins by a human tumor cell line. Eur J Biochem (1980) 1.90
Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet (1996) 1.89
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest (1979) 1.87
Characterization of protease-resistant fragments of laminin mediating attachment and spreading of rat hepatocytes. J Biol Chem (1983) 1.87
Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res (2001) 1.85
Recognition of the laminin E8 cell-binding site by an integrin possessing the alpha 6 subunit is essential for epithelial polarization in developing kidney tubules. J Cell Biol (1990) 1.85
Neural crest cell migration: requirements for exogenous fibronectin and high cell density. J Cell Biol (1983) 1.84
Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet (1994) 1.83
Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPlase) activity. Mol Microbiol (1992) 1.83
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study. Eur J Endocrinol (2007) 1.83
Binding of the proteoglycan decorin to collagen type VI. J Biol Chem (1992) 1.83
Antibodies to distinct types of collagens and procollagens and their application in immunohistology. J Immunol Methods (1977) 1.82
Synthesis of type IV collagen and laminin in cultures of skeletal muscle cells and their assembly on the surface of myotubes. Dev Biol (1982) 1.82
Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet (2001) 1.81
Synthesis and extracellular deposition of fibronectin in chondrocyte cultures. Response to the removal of extracellular cartilage matrix. J Cell Biol (1978) 1.81
The crystal structure of a laminin G-like module reveals the molecular basis of alpha-dystroglycan binding to laminins, perlecan, and agrin. Mol Cell (1999) 1.80
A transport form of collagen from embryonic tendon: electron microscopic demonstration of an NH 2 -terminal extension and evidence suggesting the presence of cystine in the molecule (chick embryo-tropocollagen-gel filtration). Proc Natl Acad Sci U S A (1972) 1.79
Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc Natl Acad Sci U S A (1997) 1.78
Cell attachment properties of collagen type VI and Arg-Gly-Asp dependent binding to its alpha 2(VI) and alpha 3(VI) chains. Exp Cell Res (1989) 1.77
Specificity of the antibody response in inbred mice to bovine type I and type II collagen. Immunology (1975) 1.77
Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane. Eur J Biochem (1984) 1.77
Identification of the sites in collagen alpha-chains that bind serum anti-gelatin factor (cold-insoluble globulin). Biochem J (1978) 1.76
Domains of laminin with growth-factor activity. Cell (1989) 1.75
Comparative distribution of laminin, type IV collagen, and fibronectin in the rat glomerulus. J Histochem Cytochem (1982) 1.75
Subunit structure and assembly of the globular domain of basement-membrane collagen type IV. Eur J Biochem (1984) 1.74
A nonsense mutation in MSX1 causes Witkop syndrome. Am J Hum Genet (2001) 1.74
Isolation, chemical and electron microscopical characterization of neutral-salt-soluble type III collagen and procollagen from fetal bovine skin. Hoppe Seylers Z Physiol Chem (1975) 1.73